Languages
  • Français
  • English
  • Leadership
  • Our Pipeline
    • Viaskin™ Peanut
    • Viaskin™ Milk
    • Viaskin™ Egg
    • Expanded Access Program
    • Scientific Publications & Presentations
  • Viaskin® Platform
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Financial Information
      • SEC Filings
      • AMF Regulated Information
      • Annual Reports & General Meetings
    • Stock Information
    • Investor FAQs
    • Corporate Governance
      • Board of Directors
      • Audit Committee
      • Compensation Committee
      • Nominating Committee
  • Careers
  • Contact Us
The epicutaneous immunotherapy company
  • Leadership
  • Our Pipeline
    • Viaskin™ Peanut
    • Viaskin™ Milk
    • Viaskin™ Egg
    • Expanded Access Program
    • Scientific Publications & Presentations
  • Viaskin® Platform
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Financial Information
      • SEC Filings
      • AMF Regulated Information
      • Annual Reports & General Meetings
    • Stock Information
    • Investor FAQs
    • Corporate Governance
      • Board of Directors
      • Audit Committee
      • Compensation Committee
      • Nominating Committee
  • Careers
  • Contact Us

Evercore HealthconX

Home » Events » Evercore HealthconX
Loading Events

« All Events

  • This event has passed.

Evercore HealthconX

December 1, 2020 - December 3, 2020

  • « DBV Technologies Provides Update on Viaskin Peanut BLA for Children Ages 4-11 Years
  • DBV Technologies Provides Update on Investigational Viaskin™ Peanut for Children Ages 4-11 Years »

The fireside chat will take place on Tuesday, December 1, 2020 at 12:35PM ET.

Watch the webcast

+ Google Calendar+ iCal Export

Details

Start:
December 1, 2020
End:
December 3, 2020
Event Category:
Webinar
  • « DBV Technologies Provides Update on Viaskin Peanut BLA for Children Ages 4-11 Years
  • DBV Technologies Provides Update on Investigational Viaskin™ Peanut for Children Ages 4-11 Years »
  • About Us
  • Leadership
  • Our Pipeline
  • Viaskin® Platform
  • Investors & Media
  • Contact Us
Follow Us
© 2018 DBV Technologies. All rights reserved.
DBV Technologies therapies are investigational and not FDA approved.
  • Terms of Use
  • Your California Privacy Rights
DBV Technologies Provides Update on Viaskin Peanut BLA for Children Ages 4-11 Years
DBV Technologies Provides Update on Investigational Viaskin™ Peanut for Children Ages 4-11 Years